MINI FUTURE OPTIONSSCHEIN PUT - AMGEN | Market Closed - Börse Stuttgart 15:37:14 2024-05-17 EDT | ||
| 11.6 EUR | +2.20% |
|
| Current month | -25.26% | ||
| 1 month | -29.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 11.6 | +2.20% |
| 24-05-16 | 11.35 | +2.53% |
| 24-05-15 | 11.07 | -6.97% |
| 24-05-14 | 11.9 | -2.78% |
| 24-05-13 | 12.24 | +2.51% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 03:37 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DQ0AYQ |
| ISIN | DE000DQ0AYQ2 |
| Date issued | 2024-02-08 |
| Strike | 436.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.91 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.78 € |
|---|---|
| Lowest since issue | 11.06 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat